BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32470891)

  • 1. Cervical human papillomavirus DNA detection in women living with HIV and HIV-uninfected women living in Limbe, Cameroon.
    Adedimeji A; Ajeh R; Dzudie A; Kendowo E; Fuhngwa N; Nsame D; Simo-Wambo AG; Orock E; Hebert TM; Pierz AJ; Murokora D; Anastos K; Castle PE
    J Clin Virol; 2020 Jul; 128():104445. PubMed ID: 32470891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
    Rodrigues LLS; Morgado MG; Sahasrabuddhe VV; De Paula VS; Oliveira NS; Chavez-Juan E; Da Silva DM; Kast WM; Nicol AF; Pilotto JH
    Gynecol Oncol; 2018 Oct; 151(1):102-110. PubMed ID: 30087059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and distribution of cervical high-risk human papillomavirus and cytological abnormalities in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rønsholt FF; Johansen IS; Pedersen G; Hashemi L; Nielsen LN; Nilas L; Obel N; Bonde J; Lebech AM
    BMC Cancer; 2016 Nov; 16(1):866. PubMed ID: 27821088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa.
    Hanisch RA; Sow PS; Toure M; Dem A; Dembele B; Toure P; Winer RL; Hughes JP; Gottlieb GS; Feng Q; Kiviat NB; Hawes SE;
    J Clin Virol; 2013 Dec; 58(4):696-702. PubMed ID: 24210330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of cervical high-risk human papillomavirus in women living with HIV in Denmark - the SHADE.
    Thorsteinsson K; Ladelund S; Storgaard M; Katzenstein TL; Johansen IS; Pedersen G; Rönsholt FF; Nielsen LN; Nilas L; Franzmann M; Obel N; Lebech AM; Bonde J
    BMC Infect Dis; 2019 Aug; 19(1):740. PubMed ID: 31438877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Côte d'Ivoire, 2010.
    Jaquet A; Horo A; Charbonneau V; Ekouevi DK; Roncin L; Toure B; Coffie P; Minga A; Sasco AJ; Garrigue I; Fleury H; Dabis F;
    Br J Cancer; 2012 Jul; 107(3):556-63. PubMed ID: 22782349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.
    Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K
    PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
    J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
    Agyare Gyane F; Modey E; Maya E; Bonney EY; Abaidoo-Myles A; Paintsil E; Torpey K
    PLoS One; 2024; 19(5):e0303535. PubMed ID: 38814956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of screening tests for detection of high-grade cervical abnormalities in women living with HIV from Cameroon.
    Castle PE; Ajeh R; Dzudie A; Kendowo E; Fuhngwa N; Simo-Wambo AG; Nsame D; Orock E; Hebert TM; Pierz AJ; Murokora D; Anastos K; Adedimeji A
    Infect Agent Cancer; 2020; 15():45. PubMed ID: 32676125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and correlates of cervical HPV infection in a clinic-based sample of HIV-positive Hispanic women.
    Ortiz AP; Tamayo V; Scorsone A; Soto-Salgado M; Febo I; Piovanetti P; Venegas-Ríos HL; Yamamura Y; Zorrilla C
    Papillomavirus Res; 2017 Dec; 4():39-44. PubMed ID: 29179868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Cholli P; Bradford L; Manga S; Nulah K; Kiyang E; Manjuh F; DeGregorio G; Ogembo RK; Orock E; Liu Y; Wamai RG; Sheldon LK; Gona PN; Sando Z; Welty T; Welty E; Ogembo JG
    Gynecol Oncol; 2018 Jan; 148(1):118-125. PubMed ID: 29153541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and genotyping of human papillomavirus (HPV) in HIV-infected women and its relationship with HPV/HIV co-infection.
    Badial RM; Dias MC; Stuqui B; Melli PPDS; Quintana SM; Bonfim CMD; Cordeiro JA; Rabachini T; Calmon MF; Provazzi PJS; Rahal P
    Medicine (Baltimore); 2018 Apr; 97(14):e9545. PubMed ID: 29620669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea.
    Park EK; Cho H; Lee SH; Lee SG; Lee SY; Kim KH; Lee CH; Chung JS; Kwak IS
    J Korean Med Sci; 2014 Jan; 29(1):32-7. PubMed ID: 24431902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus type-specific risk of cervical cancer in a population with high human immunodeficiency virus prevalence: case-control study.
    Naucler P; Mabota da Costa F; da Costa JL; Ljungberg O; Bugalho A; Dillner J
    J Gen Virol; 2011 Dec; 92(Pt 12):2784-2791. PubMed ID: 21900420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus is a driven factor of human papilloma virus among women: evidence from a cross-sectional analysis in Yaoundé, Cameroon.
    Sosso SM; Tchouaket MCT; Fokam J; Simo RK; Torimiro J; Tiga A; Lobe EE; Ambada G; Nange A; Semengue ENJ; Nka AD; Tala V; Chenwi C; Abba A; Ka'e AC; Yagai B; Colizzi V; Ndjolo A
    Virol J; 2020 May; 17(1):69. PubMed ID: 32430034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus genotypes detected in clinician-collected and self-collected specimens from women living in the Mississippi Delta.
    Castle PE; Gage JC; Partridge EE; Rausa A; Gravitt PE; Scarinci IC
    BMC Infect Dis; 2013 Jan; 13():5. PubMed ID: 23289357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
    Cicconi P; Wells C; McCarthy B; Wareing S; Andersson MI; Fox J; Lwanga J; Pal N; Burns F; Woodward C; Malek R; Sabin CA; Dorrell L
    HIV Med; 2022 Apr; 23(4):390-396. PubMed ID: 35243750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.
    Videla S; Darwich L; Cañadas MP; Paredes R; Tarrats A; Castella E; Llatjos M; Bofill M; Clotet B; Sirera G;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):168-75. PubMed ID: 19131892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.